Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$34.27 - $40.01 $38.6 Million - $45 Million
-1,125,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$34.07 - $39.94 $11.3 Million - $13.3 Million
332,500 Added 41.96%
1,125,000 $41.4 Million
Q3 2020

Nov 13, 2020

BUY
$38.11 - $42.99 $476,375 - $537,375
12,500 Added 1.6%
792,500 $29.8 Million
Q2 2020

Aug 14, 2020

SELL
$37.87 - $43.58 $2.27 Million - $2.61 Million
-60,000 Reduced 7.14%
780,000 $31.8 Million
Q1 2020

May 15, 2020

BUY
$32.47 - $48.83 $1.2 Million - $1.81 Million
37,100 Added 4.62%
840,000 $31.8 Million
Q4 2019

Feb 07, 2020

SELL
$42.0 - $48.25 $1.56 Million - $1.79 Million
-37,100 Reduced 4.42%
802,900 $37.7 Million
Q3 2019

Nov 08, 2019

BUY
$40.46 - $43.52 $809,200 - $870,400
20,000 Added 2.44%
840,000 $35.9 Million
Q1 2019

May 14, 2019

BUY
$38.57 - $42.69 $31.6 Million - $35 Million
820,000 New
820,000 $34.3 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.